ARCHIVES

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

Cooperative Group Trials Approved By NCI Are Listed

August 26, 2005

NCI Bypass Budget Published, Seeks $2.7 Billion In FY98

June 14, 1996

CPRIT Awards 32 Grants

November 21, 2014

DCCP Board Okays New Projects In Chemoprevention, Other Programs Totaling $5 Million In First Year

December 14, 1979

Accelerated Approval In Oncology Shaves A Year Off Development Time, FDA Data Show

October 30, 2009

FDA Approves BMS’s Yervoy For Metastatic Melanoma

March 25, 2011